|Relationship between periodontal disease and medical osteonecrosis of the jaw
|MEDICATION-RELATED OSTEONECROSIS OF JAW (MR-ONJ) IN OSTEOPOROSIS PATIENTS: RECENT EXPERIENCE DATA FROM PIEMONTE – VALLE D’AOSTA
|Er:YAG laser for bone vaporization and Auto-Fluorescence as a guide in highlighting surgical margins: a new surgical approach.
|OSTEONECROSIS OF JAW AFTER SUNITINIB AND DENOSUMAB: WHEN BONE SCAN IS MORE SENSIBLE THAN COMPUTED TOMOGRAPHY. A CASE REPORT
|THE IMPORTANCE OF PREVENTIVE DENTAL PROCEDURES STRATEGIES REDUCING THE RISK OF BRONJ IN CANCER PATIENTS WITH BONE METASTASIS: A SINGLE CENTER EXPERIENCE.
|Lack of adherence to periodontal supportive therapy in oncological patients treated with bone targeting agents. Do it play a role in ONJ development?
|Early treatment of Medication-related osteonecrosis of the jaws: comparison between surgical and non-surgical approach.
|MRONJ: presence of suppuration as a prognostic factor for surgical interventions.
|SPECT-CT vs CT in identifying MRONJ-affected bone. Correlation with surgical and histopathological findings. Preliminary results.
|Radiological differences among ONJ patients affected from ONJ and negative patients under use of endovenous bisphosphonates
|Validation of prognostic impact of CT in medication-related osteonecrosis of the jaw: a longitudinal study
|Attestato di merito
|Retrospective analysis of BP therapy in 1663 oncological and hematological patients between 2007 and 2016. Effect of dental prevention on ONJ incidence.
|Prevalence of mandibular fracture among 328 patients with medication-related osteonecrosis of jaws (MRONJ)
|Surgical treatment of medication-related osteonecrosis of the jaws with addiction of L-PRF: preliminary results.
|L-PRF AND LLLT as adjuvant treatments in MRONJ: case series
|A statistical evaluation of risk factors related to ONJ onset: a retrospective survey.
|Development of OloHealth, a teledentistry platform for the ONJ prevention in Sicily: preliminary reports.
|Conservative surgical treatment of Medical Related Osteonecrosis of the Jaw: experience of a single institution
|Effect of leukocyte and platelet-rich fibrin (L-PRF) on the treatment of BRONJ
|ROLE OF NUCLEAR MEDICINE IMAGING TECHNIQUES IN EARLY DIAGNOSIS OF ONJ IN PROSTATE CANCER PATIENTS: REPORT OF A DEMONSTRATIVE CASE
|Oral bisphosphonates; patients’ lack of knowledge could increase MRONJ risk. Surgical management improved with the aid of SPECT-CT
|Premio per i poster
|Clinical course and therapeutic outcomes in medication-related osteonecrosis of the jaw. Our experience in the last two years.
|Ten-years of clinical experience in medication-related osteonecosis of the jaw.
|DENOSUMAB RELATED OSTEONECROSIS OF JAW : A SINGLE CENTRE FIVE-YEAR EXPERIENCE
|MRONJ around fixtures: clinical aspects, treatment and outcome in 6 patients.
|Use of autologous platelet-rich fibrin (A-PRF and i-PRF) in the treatment of a massive medication-related osteonecrosis of the jaw (MRONJ
|Multifocal MRONJ: a report of six cases
|Stage III Medication-Related Osteonecrosis in patients treated with oral-bisphosphonate: 4 Case Reports
|Platelet Rich Fibrin (PRF) Vivostat as a possible alternative for MRONJ treatment: a case report.
|An unusual case of osteonecrosis of the jaw in a renal cell carcinoma patient treated with sunitinib alone.
|B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) for the surgical treatment of patients at risk of maxillary osteonecrosis, related to bisphosphonates (BRONJ)
|Is the Presence of dental implants a local risk factor for MRONJ?
|Autologous platelet concentrates for treatment and prevention of medication-related osteonecrosis of the jaw (MRONJ). A systematic review of the literature
|Milano San Raffaele
|Low-level laser therapy in the treatment of osteonecrosis of the jaws: prospective study
|B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) for the treatment of maxillary osteonecrosis, related to bisphosphonates (BRONJ)
|Stage III Medication-Related Osteonecrosis of the Posterior Maxilla: Surgical Treatment Using a Pedicled Buccal Fat Pad Flap: five Case Reports